SCHEMBL7009206

SCHEMBL7009206

COC(=O)c1ccc(-n2cccc2C=O)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.63
ATM Q13315 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.55
CYP1A2 P05177 1/20 0.55
GAA P10253 2/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
FGFR1 P11362 1/20 0.48
HTT P42858 2/20 0.46
TDP1 Q9NUW8 2/20 0.45
POLB P06746 1/20 0.45
APEX1 P27695 1/20 0.45
RECQL P46063 1/20 0.45
TSHR P16473 1/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
FBP1 P09467 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7816834 0.84 L3MBTL1 (0.55) ALDH1A1ATML3MBTL1CYP1A2GAA
SCHEMBL9042897 0.84 ALDH1A1 (0.62) ALDH1A1ATML3MBTL1CYP1A2SMN1; SMN2
SCHEMBL2558718 0.81 ATM (0.68) ALDH1A1ATML3MBTL1CYP1A2SMN1; SMN2
SCHEMBL27571544 0.80 CA1 (0.52) ALDH1A1L3MBTL1SMN1; SMN2FGFR1HTT
SCHEMBL7007417 0.80 TDP1 (0.52) ALDH1A1L3MBTL1SMN1; SMN2FGFR1HTT
SCHEMBL7822354 0.79 CA12 (0.49) ALDH1A1ATML3MBTL1CYP1A2GAA
SCHEMBL27523948 0.78 FGFR1 (0.50) ALDH1A1L3MBTL1SMN1; SMN2FGFR1HTT
SCHEMBL5786109 0.78 CYP1A2 (0.54) ALDH1A1ATML3MBTL1CYP1A2GAA
SCHEMBL28432330 0.77 ALDH1A1 (0.51) ALDH1A1GAACA12CA1CA2
SCHEMBL6377479 0.76 FGFR1 (0.55) ALDH1A1L3MBTL1FGFR1HTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed